Showing results (1971-1980 of 5,761) with videos related to
Sort By:
Pageof 577
Clinical and Experimental Immunology|May 1, 1979
Ontogeny of T cells, B cells and monocytes in the bovine foetusD R Senogles, P S Paul, D W Johnson, et al.American Journal of Ophthalmology|January 30, 2008
Vitreous penetration of orally administered valacyclovirTony H Huynh, Mark W Johnson, Grant M Comer, et al.The Journal of Nutrition|October 15, 1998
Pretreatment of young pigs with vitamin E attenuates the elevation in plasma interleukin-6 and cortisol caused by a challenge dose of lipopolysaccharideD M Webel, D C Mahan, R W Johnson, et al.The Cochrane Database of Systematic Reviews|February 7, 2008
Treatment for peritoneal dialysis-associated peritonitisK J Wiggins, J C Craig, D W Johnson, et al.American Heart Journal|March 1, 1990
PTCA of the left coronary artery when the right coronary artery is chronically occludedP Teirstein, L Giorgi, W Johnson, et al.Biochimica Et Biophysica Acta|October 23, 2012
Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localizationSoner Gundemir, Gozde Colak, Julianne Feola, et al.The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|September 30, 1998
Salmonella typhimurium DT104: a virulent and drug-resistant pathogenC Poppe, N Smart, R Khakhria, et al.Journal of Pharmaceutical Sciences|August 1, 1979
Synthesis of substituted 2-aminopyrrole analogs of lidocaine IIR W Johnson, T H Keenan, J W Kosh, et al.Inorganic Chemistry|December 6, 2005
Synthesis and characterization of two isomeric, self-assembled arsenic-thiolate macrocyclesW Jake Vickaryous, Elisabeth Rather Healey, Orion B Berryman, et al.Neuropharmacology|May 14, 2018
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances ActMatthew W Johnson, Roland R Griffiths, Peter S Hendricks, et al.Pageof 577